Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» JNJ launches PhII lymphoma study for daratumumab
JNJ launches PhII lymphoma study for daratumumab
JNJ launches PhII lymphoma study for daratumumab
Submitted by
admin
on December 4, 2014 - 10:47am
Source:
Fierce Biotech
News Tags:
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
Headline:
JNJ launches PhII lymphoma study for daratumumab
Do Not Allow Advertisers to Use My Personal information
